Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Sara Saberi et al.|The Lancet|2020Cited by 1.2k
Impact of local delivery of allogeneic chondrocytes on the biological response and healing of the sternum bones after sternotomyAgata Krauze, Wojciech Wojakowski|Scientific Reports|2023Cited by 2
Accuracy of on-site CT-μFR analyses for evaluation of intermediate coronary stenoses in patients undergoing TAVIAdrian Bednarek, Mariusz Tomaniak, Natan Adamów et al.|Journal of cardiovascular computed tomography|2025Cited by 0